 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
Elektrovej Building 375 2800 Lyngby
Denmark
|
|
Portrait Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
Industrial Sectors
Additional information
Symphogen A/S Lyngby, Denmark
News
|
|
|
|
|
|